Tamkeen Khan +6 more
doaj +1 more source
The Impact of Glucagon-like Peptide-1 Receptor Agonists on Erectile Function: Friend or Foe? [PDF]
Kounatidis D +6 more
europepmc +1 more source
Glucagon-Like Peptide-1 Receptor Agonists in Neurodegenerative Diseases: A Comprehensive Review. [PDF]
Ibrahim R, Kambal A, Abdelmajeed MA.
europepmc +1 more source
Glucagon-Like Peptide-1 Receptor Agonists Versus Bariatric Surgery in Patients With Obesity and Heart Failure With Preserved Ejection Fraction. [PDF]
Ibrahim R +14 more
europepmc +1 more source
Impact of weight‐loss interventions on psoriasis severity: A systematic review and meta‐analysis
Weight‐loss interventions were associated with clinically and statistically significant improvements in psoriasis severity (PASI and PASI 75) and quality of life (DLQI). These findings support the role of weight‐loss interventions as effective adjuncts to medical therapy and their integration into holistic psoriasis care.
Sarah Morrow +6 more
wiley +1 more source
Roux-en-Y Gastric Bypass Compared to Glucagon-like Peptide-1 Receptor Agonists is Associated with Lower Out-of-Pocket Costs in Insured Patients with Type 2 Diabetes and Obesity [PDF]
Sibi Krishna Thiyagarajan +4 more
openalex +1 more source
Association of glucagon-like peptide-1 receptor agonists with risk of gastrointestinal adverse events: evidence from a drug target Mendelian randomization. [PDF]
Huang H, Liu J, Lu X, Tan N, Liu Y.
europepmc +1 more source

